# Templeton Emerging Markets Fund (EMF) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Financial Services / Capital Markets. Price $20.45, market value $305 million.

## Valuation
- **P/E (trailing): 2.1×** (5-yr avg 7.4×, 3-yr avg 7.4×). Templeton Emerging Markets Fund trades at 2.1× trailing earnings, well below its own five-year average of 7.4×: cheap by its own standards. The Financial Services median in the September 2026 study was 13.1×.
- **Price / sales: 2.1×**. Each dollar of revenue is priced at 2.1×.
- **Price / book: 0.8×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Earnings yield: 46.7%**. The inverse of the P/E: 46.7% of the price is earned each year.

## Profitability
- **Net margin: 99.6%**. 99.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 38.0%**. 38.0% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on assets: 36.5%**. Each dollar of assets produces 36.5% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): 395.2%**. Revenue grew 395.2% over the last year.

## Dividends
- **Dividend yield: 4.69%** ($0.96 per share, trailing). Templeton Emerging Markets Fund yields 4.69%, an income-level yield.
- **Consecutive years of increases: 1**. 1 straight year of increases.
- **Dividend growth (5 yr): 28.3%/yr** (1-yr 224.1%). The dividend has compounded at 28.3% a year over five years, doubling roughly every 3 years at that pace.

## Price and momentum
- **Total return (1 yr): 27.4%** (YTD 23.9%, 3-mo -3.6%). The shares are up 27.4% over twelve months including dividends.
- **From 52-week high: -17.2%** (26.5% above the low). Trading 17% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 34**. An RSI of 34 is neutral.
- **Beta (1 yr): 1.38** (volatility 28%). Beta of 1.38 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EMF · Page: https://foliofundamentals.com/stocks/emf

Not investment advice.
